Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men: A prospective cohort study

Archives of Internal Medicine

Volumn 164, Issue 14, 2004, Pages 1546-1551

  Niskanen, Leo K ^a   Laaksonen, David E ^a   Nyyssönen, Kristiina ^b   Alfthan, Georg ^c   Lakka, Hanna Maaria ^d,e   Lakka, Timo A ^d   Salonen, Jukka T ^b,e,f  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b Research Institute of Public Health   (Finland)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^d PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^e UNIVERSITY OF EASTERN FINLAND   (Finland)

^f Inner Savo Health Centre   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; FOLLOW UP; GOUT; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MORTALITY; POPULATION RESEARCH; PRIORITY JOURNAL; PROSPECTIVE STUDY; SERUM; URIC ACID BLOOD LEVEL;

BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; COHORT STUDIES; DIABETES MELLITUS; FINLAND; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MORTALITY; NEOPLASMS; PROSPECTIVE STUDIES; RISK FACTORS; URIC ACID;

EID: 3242785541     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.164.14.1546     Document Type: Article

References (51)

1. Becker BF. Towards the physiological function of uric acid. Free Radic Biol Med. 1993;14:615-631.
2. Garcia Puig J, Mateos FA. Clinical and biochemical aspects of uric acid overproduction. Pharm World Sci. 1994;16:40-54.
3. Reunanen A, Takkunen H, Knekt P, Aromaa A. Hyperuricemia as a risk factor for cardiovascular mortality. Acta Med Scand Suppl. 1982;668:49-59.
4. Bengtsson C, Lapidus L, Stendahl C, Waldenström J. Hyperuricemia and risk of cardiovascular disease and overall death: a 12-year follow-up of participants in the population study of women in Gothenburg, Sweden. Acta Med Scand. 1988;224:549-555.
5. Levine W, Dyer AR, Shekelle RB, Schoenberger JA, Stamler J. Serum uric acid and 11.5-year mortality of middle-aged women: findings of the Chicago Heart Association Detection Project in Industry. J Clin Epidemiol. 1989;42:257-267.
6. Wang JG, Staessen JA, Fagard RH, Birkenhager WH, Gong L, Liu L. Prognostic significance of serum creatinine and uric acid in older Chinese patients with isolated systolic hypertension. Hypertension. 2001;37:1069-1074.
7. Freedman DS, Williamson DF, Gunter EW, Byers T. Relation of serum uric acid to mortality and ischemic heart disease: the NHANES I Epidemiologic Follow-up Study. Am J Epidemiol. 1995;141:637-644.
8. Lehto S, Niskanen L, Rönnemaa T, Laakso M. Serum uric acid is a strong predictor of stroke in patients with non-insulin-dependent diabetes mellitus. Stroke. 1998;29:635-639.
9. Alderman MH, Cohen H, Madhavan S, Kivlighn S. Serum uric acid and cardiovascular events in successfully treated hypertensive patients. Hypertension. 1999;34:144-150,
10. Culleton BF, Larson MG, Kannel WB, Levy D. Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study. Ann Intern Med. 1999;131:7-13.
11. Fang J, Alderman MH. Serum uric acid and cardiovascular mortality: the NHANES I epidemiologic follow-up study, 1971-1992. JAMA. 2000;283:2404-2410.
12. Franse LV, Pahor M, Di Bari M, et al. Serum uric acid, diuretic treatment and risk of cardiovascular events in the Systolic Hypertension in the Elderly Program (SHEP). J Hypertens. 2000;18:1149-1154.
13. Messerli FH, Frohlich ED, Dreslinski GR, Suarez DH, Aristimuno GG. Serum uric acid in essential hypertension: an indicator of renal vascular involvement. Ann Intern Med. 1980;93:817-821.
14. Puig JG, Ruilope LM. Uric acid as a cardiovascular risk factor in arterial hypertension. J Hypertens. 1999;17:869-872.
15. Lee J, Sparrow D, Vokonas PS, Lansberg L, Weiss ST. Uric acid and coronary heart disease risk: evidence for a role of uric acid in the obesity-insulin resistance syndrome: the Normative Aging Study. Am J Epidemiol. 1995;142:288-294.
16. Zavaroni I, Mazza S, Fantuzzi M, et al. Changes in insulin and lipid metabolism in males with asymptomatic hyperuricaemia. J Intern Med. 1993;234:25-30.
17. Modan A, Halkin H, Karasik A, Lusky A. Elevated serum uric acid - a facet of hyperinsulinaemia. Diabetologia. 1987;30:713-718.
18. Facchini F, Chen YD, Hollenbeck CB, Reaven GM. Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration. JAMA. 1991;266:3008-3011.
19. Vuorinen-Markkola H, Yki-Järvinen H. Hyperuricemia and insulin resistance. J Clin Endocrinol Metab. 1994;78:25-29.
20. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285:2486-2497.
21. Alexander RW. Inflammation and coronary artery disease. N Engl J Med. 1994;331:468-469.
22. Iuliano L. The oxidant stress hypothesis of atherogenesis. Lipids. 2001;36(suppl): S41-S44.
23. Aengevaeren WR. Beyond lipids-the role of the endothelium in coronary artery disease. Atherosclerosis. 1999;147(suppl 1):S11-S16.
24. Tuttle KR, Short RA, Johnson RJ. Sex differences in uric acid and risk factors for coronary artery disease. Am J Cardiol. 2001;87:1411-1414.
25. Vigna GB, Bolzan M, Romagnoni F, et al. Lipid and other risk factors selected by discriminant analysis in symptomatic patients with supra-aortic and peripheral atherosclerosis. Circulation. 1992;85:2205-2211.
26. Saggiani F, Pilati S, Targher G, Branzi P, Muggeo M, Bonora E. Serum uric acid and related factors in 500 hospitalized subjects. Metabolism. 1996;45:1557-1561.
27. Salonen JT. Is there a continuing need for longitudinal epidemiologic research? the Kuopio Ischaemic Heart Disease Risk Factor Study. Ann Clin Res. 1988;20:46-50.
28. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure [published correction appears in Arch Intern Med. 1998;158:573]. Arch Intern Med. 1997;157:2413-2446.
29. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure [published correction appears in Arch Intern Med. 1998;158:573]. Arch Intern Med. 1997;157:2413-2446.
30. Guidelines Subcommittee. 1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. J Hypertens. 1999;17:151-183.
31. Balkau B, Charles MA, European Group for the Study of Insulin Resistance (EGIR). Comment on the provisional report from the WHO consultation. Diabet Med. 1999;16:442-443.
32. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications, part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15:539-553.
33. Salonen JT, Tuomainen TP, Kontula K. Role of C282Y mutation in haemochromatosis gene in development of type 2 diabetes in healthy men: prospective cohort study. BMJ. 2000;320:1706-1707.
34. Lakka HM, Lakka TA, Tuomilehto J, Sivenius J, Salonen JT. Hyperinsulinemia and the risk of cardiovascular death and acute coronary and cerebrovascular events in men: the Kuopio Ischaemic Heart Disease Risk Factor Study. Arch Intern Med. 2000;160:1160-1168.
35. Musser AW, Ortigoza C. Automated determination of uric acid by the hydroxylamine method. Tech Bull Regist Med Technol. 1966;36:21-25.
36. Lakka TA, Venäläinen JM, Rauramaa R, Salonen R, Tuomilehto J, Salonen JT. Relation of leisure-time physical activity and cardiorespiratory fitness to the risk of acute myocardial infarction. N Engl J Med. 1994;330:1549-1554.
37. Salonen JT, Nyyssönen K, Korpela H, Tuomilehto J, Salonen R. High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men. Circulation. 1992;86:803-811.
38. Lynch J, Helmrich SP, Lakka TA, et al. Moderately intense physical activities and high levels of cardiorespiratory fitness reduce the risk of non-insulin-dependent diabetes mellitus in middle-aged men. Arch Intern Med. 1996;156:1307-1314.
39. Tuomilehto J, Sarti C, Narva EV, et al. The FINMONICA Stroke Register: community-based stroke registration and analysis of stroke incidence in Finland, 1983-1985. Am J Epidemiol 1992;135:1259-1270.
40. Tuomilehto J, Arstila M, Kaarsalo E, et al. Acute myocardial infarction (AMI) in Finland - baseline data from the FINMONICA AMI register in 1983-1985 [published correction appears in Eur Heart J. 1992;13:1153]. Eur Heart J. 1992;13:577-587.
41. Tuomilehto J, Arstila M, Kaarsalo E, et al. Acute myocardial infarction (AMI) in Finland - baseline data from the FINMONICA AMI register in 1983-1985 [published correction appears in Eur Heart J. 1992;13:1153]. Eur Heart J. 1992;13:577-587.
42. WHO Monica Project. MONICA Manual, Part IV: Event Registration. Available at: http://www.ktl.fi/publications/monica/manual/index.htm. Accessed May 13, 2002.
43. Lakka HM, Lakka TA, Tuomilehto J, Salonen JT. Abdominal obesity is associated with increased risk of acute coronary events in men. Eur Heart J. 2002;23:706-713.
44. Maclachlan MJ, Rodnan GP. Effects of food, fast, and alcohol on serum uric acid and acute attacks of gout. Am J Med. 1967;42:38-57.
45. Muscelli E, Natali A, Bianchi S, et al. Effect of insulin on renal sodium and uric acid handling in essential hypertension. Am J Hypertens. 1996;9:746-752.
46. Cappuccio FP, Strazzulio P, Farinaro E, Trevisan M. Uric acid metabolism and tubular sodium handling: results from a population-based study. JAMA. 1993;270:354-359.
47. DeFronzo RA, Cooke CR, Andres R, Faloona GR, Davis PJ. The effect of insulin on renal handling of sodium, potassium, calcium, and phosphate in man. J Clin Invest. 1975;55:845-855.
48. Lakka HM, Laaksonen DE, Lakka TA, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA. 2002;288:2709-2716.
49. Becker BF, Reinholz N, Leipert B, Raschke P, Permanetter B, Gerlach E. Role of uric acid as an endogenous radical scavenger and antioxidant. Chest. 1991;100(3, suppl):176S-181S.
50. Nyyssönen K, Porkkala-Sarataho E, Kaikkonen J, Salonen JT. Ascorbate and urate are the strongest determinants of plasma antioxidative capacity and serum lipid resistance to oxidation in Finnish men. Atherosclerosis. 1997;130:223-233.
51. Maxwell AJ, Bruinsma KA. Uric acid is closely linked to vascular nitric oxide activity: evidence for mechanism of association with cardiovascular disease. J Am Coll Cardiol. 2001;38:1850-1858.